AAC
Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Nishiyama, S.
Right arrow Articles by Moffatt, J. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nishiyama, S.
Right arrow Articles by Moffatt, J. G.

 Previous Article  |  Next Article 

Antimicrob Agents Chemother. 1977 February; 11(2): 198-201
Copyright © 1977 American Society for Microbiology. All Rights Reserved.

Comparative Study of the Antiviral Activity of Acyl Derivatives of 2,2'-Anhydro-1-ß-D-Arabinofuranosylcytosine and Other Nucleosides Against Encephalitis in Mice1

Shinya Nishiyama, Kosaburo Sato, Toshihiko Yamanaka and John G. Moffatt

Shionogi Research Laboratory, Shionogi & Co., Ltd., Fukushima-ku, Osaka, 553 Japan
Institute of Molecular Biology, Syntex Research, Palo Alto, California 94304

ABSTRACT

Anti-deoxyribonucleic acid virus activities of 3'-O-acyl derivatives of 2,2'-anhydro-1-ß-D-arabinofuranosyl cytosine (cyclo-C) and 1-ß-D-arabinofuranosylcytosine (Ara-C) were evaluated by using an in vivo test system in mice. Among the derivatives tested, 3'-O-decanoyl cyclo-C hydrochloride was the most effective against herpes simplex virus-induced encephalitis in mice when the drug was administered directly into infected brains of mice (target-organ treatment). A comparative study of the treatment of herpetic encephalitis in mice with 3'O-decanoyl cyclo-C and other nucleosides, including Ara-C, 9-ß-D-arabinofuranosyladenine (Ara-A), and 5-iodo-2'-deoxyrudine (IUdR), proved Ara-A to be more efficacious than the other nucleosides, followed by 3'-O-decanoyl cyclo-C, which was more active than Ara-C and IUdR. Administration of 3'-O-acyl cyclo-C's by intraperitoneal injection, however, failed to demonstrate activity against herpetic encephalitis in mice. The antivaccinial activity of 3'-O-decanoyl cyclo-C was also compared with that of other compounds against encephalitis and dermal tail lesions in mice caused by vaccinia virus infection. Interaperitoneally administered 3'-O-decanoyl cyclo-C and Ara-C also showed no significant activity against the diseases. Under these test conditions, N-methylisatin-ß-thiosemicarbazone (Marboran) was the most active compound, followed by Ara-A.


FOOTNOTES

1 Contribution no. 130 from the Institute of Molecular Biology, Syntex Research, Palo Alto, CA 94304.


Antimicrob Agents Chemother. 1977 February; 11(2): 198-201
Copyright © 1977 American Society for Microbiology. All Rights Reserved.







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
Clin. Vaccine Immunol. Clin. Microbiol. Rev.
J. Clin. Microbiol. ALL ASM JOURNALS

Copyright © 1977 by the American Society for Microbiology. All rights reserved.